Bastos-Oreiro, M.B. (M.B.)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
Search Results
Now showing 1 - 1 of 1
- Aprepitant in refractory pruritus of systemic lymphoproliferative disorders(Wiley, 2020) Bastos-Oreiro, M.B. (M.B.); Romero-Jimenez, R. (R.); Nieto-Benito, L.M. (Lula M.); Bergón-Sendín, M. (Marta); Dorado-Herrero, N. (N.); Pulido-Pérez, A. (Ana); Suárez-Fernández, R. (Ricardo); Lopez, A. (A.)araneoplastic pruritus represents a frequent symptom in the debut or progression of lymphoproliferative disorders. It affects approximately 30% of patients with Hodgkin lymphoma and 15% of patients with non-Hodgkin lymphoma.1 Aprepitant has shown promising results in the treatment of refractory pruritus of primary cutaneous T-cell lymphomas (CTCL).